SCHEMBL22461360

SCHEMBL22461360

CC(C)(C)OC(=O)Nc1ccc(C(=O)Nc2ccc(C(=O)O)cc2)cc1

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NAMPT P43490 1/20 0.65
MITF O75030 1/20 0.57
FFAR1 O14842 1/20 0.55
MEN1 O00255 2/20 0.55
KMT2A Q03164 2/20 0.55
EPHX2 P34913 1/20 0.54
NR1H4 Q96RI1 1/20 0.54
CYP17A1 P05093 1/20 0.51
NPC1 O15118 3/20 0.50
RAB9A P51151 3/20 0.50
SMN1; SMN2 Q16637 2/20 0.50
MAPT P10636 1/20 0.50
HDAC3 O15379 1/20 0.50
HDAC11 Q96DB2 1/20 0.50
HDAC8 Q9BY41 1/20 0.50
HDAC6 Q9UBN7 1/20 0.50
CA12 O43570 1/20 0.50
CA2 P00918 1/20 0.50
CA9 Q16790 1/20 0.50
TP53 P04637 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22461618 1.00 NAMPT (0.65) NAMPTMITFFFAR1MEN1KMT2A
SCHEMBL243401 0.94 CYP17A1 (0.56) NAMPTMITFMEN1KMT2AEPHX2
SCHEMBL21661749 0.94 NAMPT (0.72) NAMPTMEN1KMT2ACYP17A1NPC1
SCHEMBL17526122 0.91 NAMPT (0.73) NAMPTMEN1KMT2ANPC1RAB9A
SCHEMBL2062613 0.89 NAMPT (0.67) NAMPTMEN1KMT2ANPC1RAB9A
SCHEMBL8770870 0.89 NAMPT (0.67) NAMPTFFAR1MEN1KMT2ACYP17A1
SCHEMBL3360413 0.89 CYP17A1 (0.63) NAMPTEPHX2NR1H4CYP17A1MAPT
SCHEMBL8773493 0.89 NAMPT (0.67) NAMPTMEN1KMT2ANR1H4CYP17A1
SCHEMBL22440673 0.88 STAT3 (0.57) NAMPTMITFFFAR1MEN1KMT2A
SCHEMBL22440689 0.88 STAT3 (0.57) NAMPTMITFFFAR1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200298194-A1 ARAMID AMPHIPHILE SELF-ASSEMBLED NANOSTRUCTURES MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2020-09-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200298194-A1 ARAMID AMPHIPHILE SELF-ASSEMBLED NANOSTRUCTURES ANXA6, ANXA1, ANXA11 NAMPT 1706/4885MITF 2173/4885FFAR1 3061/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.